Nav: Home

Five early-career cancer researchers selected as Pew-Stewart scholars

June 09, 2016

PHILADELPHIA -- The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced today the 2016 class of Pew-Stewart scholars for cancer research.

Five scientists from top research institutions in the United States were selected for their dedication to pursuing innovative leads aimed at finding a cure for cancer. Each will receive four years of flexible funding to conduct their work.

"Cancer is a devastating disease, causing pain for millions of patients and their loved ones across the world," said Rebecca W. Rimel, president and CEO of The Pew Charitable Trusts. "We expect that these scientists and their cutting-edge work will contribute greatly to the fight against this illness."

For three years, Pew has partnered with the Alexander and Margaret Stewart Trust to support early-career researchers. The initiative has allowed for the Pew Scholars Program in Biomedical Sciences, a three-decade-old scholarship program for promising, young scientists, to expand its reach while also supporting an area of great need -- cancer research. The 2016 Pew-Stewart scholars' work includes studying what drives recurrence of medulloblastoma, an aggressive pediatric brain tumor, and engineering new immune therapies against pancreatic cancer.

"These scientists are truly exceptional -- they meet our committee's expectations for excellence and diligence in every way. Their efforts will be critical to unraveling the mysteries of cancer in the years to come," said Peter M. Howley, M.D., chair of the Pew-Stewart national advisory committee.

In addition to the 2016 class of Pew-Stewart scholars, the new classes of Pew biomedical scholars and Latin American fellows were also announced today.

The 2016 Pew-Stewart scholars for cancer research are:

Stephanie K. Dougan, Ph.D.
Dana-Farber Cancer Institute
Cancer immunology

Dirk Hockemeyer, Ph.D.
University of California, Berkeley
Molecular biology

Paul A. Northcott, Ph.D.
St. Jude Children's Research Hospital
Genetics; cancer biology

Richard L. Possemato, Ph.D.
New York University Langone Medical Center
Molecular biology; metabolism

Ömer H. Yilmaz, M.D., Ph.D.
Massachusetts Institute of Technology
biology

Visit the program page to read the scholars' full abstracts and learn more about the program.
-end-
The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Learn more at http://www.pewtrusts.org.

The Alexander and Margaret Stewart Trust, established in 1947, is a charitable foundation supporting nonprofit organizations that research, treat, and prevent cancer and pediatric illnesses. Learn more at http://www.stewart-trust.org.

Pew Charitable Trusts

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.